14 results
Treatment Algorithm for Pulmonary Hypertension

#Pulmonary #Hypertension #PAH #Treatment #Management #Algorithm #Medications
Treatment Algorithm ... for Pulmonary Hypertension ... #Pulmonary # ... Hypertension #PAH ... #Treatment #Management
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
management in Pulmonary ... Arterial Hypertension ... #PAH #Management ... #Algorithm #treatment ... #pharmacology
Low / Intermediate Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH
Arterial Hypertension ... (PAH) Management ... Algorithm Dr. ... #Algorithm #treatment ... #pharmacology
Outpatient Hypertension Management Algorithm
Monotherapy: 
 • Thiazide/thiazide-like 
 • ACE-I (non-black patients), 
 • ARB
Outpatient Hypertension ... Management Algorithm ... Acute Coronary Syndrome ... Amy Chung, MD, MSc ... #Management #Algorithm
High Risk Pulmonary Arterial Hypertension (PAH) Management Algorithm

Dr. John Ryan @JJRyanMD

#Pulmonary #Arterial #Hypertension #PAH #Management #Algorithm
High Risk Pulmonary ... Arterial Hypertension ... (PAH) Management ... Algorithm Dr. ... #Algorithm #treatment
Guide to Acute Kidney Injury (AKI)

What to ask/look for: 
 - HPI, PMH, full ROS
AKI) What to ask ... for: - HPI, PMH ... - Recent hypo/hypertension ... - Urine Na/K/Cl ... Nephrology #Diagnosis #Algorithm
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
disequilibrium syndrome ... Inhibitors of Na+K+2Cl ... Torsemide) • Acute pulmonary ... Tolvaptan) • Treatment ... Diuresis #Nephrology #Pharmacology
Differentiation Syndrome in APML
Epidemiology:
 • Incidence: common in APL (2-48% depending on the study)
 • Triggers:
Differentiation Syndrome ... Incidence: common in APL ... Triggers: ATRA treatment ... Imaging: CXR- pulmonary ... Renal Failure Treatment
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
, INC risk PE, Pulmonary ... amyloidosis, PAH ... phenomenon (16%) MSK ... Adenocarcinoma Treatment ... lubricants • Pharmacologic
Summary of Oncologic Emergencies

Neutropenic fever:
- Fever + ANC < 500 → start cefepime ± vancomycin (if
rash, hypoxia, hypotension ... : - Seen with AML ... (~20 %) and APL ... , weight gain, hypotension ... renal failure, pulmonary